Innate cellular immunity in the immunopathogenesis of HIV-1 infection in Uganda

HIV/AIDS has widespread effects in many developing countries and severely undermines efforts for sustainable development and poverty reduction. An effective vaccine remains a distant goal and increased efforts are necessary to understand the pathogenesis

ID Projet
SE-0-SE-29-3311-3311-2011-7293-285-99810
Statut de l'activité
4 - Post-completion
Type d'aide
D02 - Autres formes d’assistance technique
% to Ouganda
100.00

Organisations

Funding
Sweden
Implementing
University, college or other teaching institution, research institute or think-tank
Extending
The Swedish Research Council

Versements par exercice fiscal, trimestre

Exercice fiscal Trimestre fiscal Montant (USD) Ouganda Montant (USD)
2013 Q2 35,773.51 35,773.51

Engagements par exercice fiscal, trimestre

Exercice fiscal Trimestre fiscal Montant (USD) Ouganda Montant (USD)

Projections de CDMT par exercice fiscal

Exercice fiscal Montant (USD) Ouganda Montant (USD)

Code CRS %
Secteur non spécifié (99810) 100.0